It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Bogan reports the following financial relationships:
Consultant: Alkermes; Apnimed, Inc.; Avadel; Daiichi Sankyo, Inc.; Eisai Inc.; Harmony Biosciences; and Takeda Pharmaceutical Company Limited
Research Support: Apnimed, Inc.; AstraZeneca; Avadel; Axsome Therapeutics, Inc.; Balance; Bayer; Bresotec Medical; Centessa Pharmaceuticals; Eisai Inc.; Fisher & Paykel Healthcare Limited; Fresca Medical, Inc.; Idorsia Pharmaceuticals; Insilico Medicine; Jazz Pharmaceuticals, Inc.; LivaNova; Merck & Co., Inc.; Mineralys Therapeutics, Inc.; NLS Pharmaceutics; Noctrix; Oura; Philips; Rho, Inc.; Roche; Sanofi; Sommetrics, Inc.; Suven Life Sciences; Takeda Pharmaceutical Company Limited; Zevra Therapeutics; and ZiO Health Ltd
Speakers Bureau for Axsome Therapeutics, Inc.; Eisai Inc.; Harmony Biosciences; Idorsia Pharmaceuticals; and Jazz Pharmaceuticals, Inc.
Shareholder: Healthy Humming, LLC and Watermark Medical
Board of Directors: Watermark Medical
Dr. Morse reports the following financial relationships:
Advisory Board: Alkermes; Apnimed, Inc.; Avadel; FloraWorks; Jazz Pharmaceuticals, Inc.; Pulse Infoframe, Inc.; and Neura Health
Consultant: Alkermes; Apnimed, Inc.; Avadel; Harmony Biosciences; Jazz Pharmaceuticals, Inc.; and Takeda Pharmaceutical Company
Grants: Harmony Biosciences and Resmed
Research Support: Avadel; Jazz Pharmaceuticals, Inc.; National Institutes of Health (NIH); Takeda Pharmaceutical Company; and UCB, Inc.
Speakers Bureau: Avadel; Harmony Biosciences; and Lilly
Stock Shareholder (ownership interest): Floraworks (SAB)
Other financial or material support: UpToDate and Forbes
The following individuals have no financial relationships to disclose:
Rebecca Vargas-Jackson, MD (Peer Reviewer)
Michael Franks, APRN, AGACNP-BC, FNP-BC (Peer Reviewer)
Mary Gleason, PhD, CHCP (Planning Committee)
Felicia Oyedepo, MD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
*All identified conflicts of interest have been mitigated.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
